Literature DB >> 21698398

Prevalence and diagnostic outcome relating to vitamin D deficiency in new patients presenting to an early arthritis clinic over 12 months.

Faye A H Cooles, Arthur G Pratt, Gillian Wilson, John D Isaacs, Wan-Fai Ng.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21698398     DOI: 10.1007/s10067-011-1800-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  4 in total

1.  The prevalence of vitamin D deficiency in consecutive new patients seen over a 6-month period in general rheumatology clinics.

Authors:  Muhammad Haroon; Ursula Bond; Niamh Quillinan; Mark J Phelan; Michael J Regan
Journal:  Clin Rheumatol       Date:  2010-12-24       Impact factor: 2.980

Review 2.  Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity.

Authors:  Diane L Kamen; Vin Tangpricha
Journal:  J Mol Med (Berl)       Date:  2010-02-01       Impact factor: 4.599

3.  Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability.

Authors:  Maurizio Rossini; Susanna Maddali Bongi; Giovanni La Montagna; Giovanni Minisola; Nazzarena Malavolta; Luigi Bernini; Enrico Cacace; Luigi Sinigaglia; Ombretta Di Munno; Silvano Adami
Journal:  Arthritis Res Ther       Date:  2010-11-29       Impact factor: 5.156

4.  Hypovitaminosis D among rheumatology outpatients in clinical practice.

Authors:  M Mouyis; A J K Ostor; A J Crisp; A Ginawi; D J Halsall; N Shenker; K E S Poole
Journal:  Rheumatology (Oxford)       Date:  2008-05-22       Impact factor: 7.580

  4 in total
  1 in total

1.  Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study.

Authors:  Ana Urruticoechea-Arana; María A Martín-Martínez; Santos Castañeda; Carlos A Sanchez Piedra; Carlos González-Juanatey; Javier Llorca; Federico Díaz-Gonzalez; Miguel A González-Gay
Journal:  Arthritis Res Ther       Date:  2015-08-14       Impact factor: 5.156

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.